Distribution of cannabinoid receptors in the central and peripheral nervous system
- PMID: 16596779
- DOI: 10.1007/3-540-26573-2_10
Distribution of cannabinoid receptors in the central and peripheral nervous system
Abstract
CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has a characteristic distribution in the nervous system: It is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum--a distribution that corresponds to the most prominent behavioral effects of cannabis. In addition, this distribution helps to predict neurological and psychological maladies for which manipulation of the endocannabinoid system might be beneficial. CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses. While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 years, there is still more to learn. Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the determination of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.
Similar articles
-
Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.Histochem Cell Biol. 2018 Aug;150(2):187-205. doi: 10.1007/s00418-018-1684-7. Epub 2018 Jun 7. Histochem Cell Biol. 2018. PMID: 29882158
-
Expression and localization of cannabinoid receptors in human immature oocytes and unfertilized metaphase-II oocytes.Reprod Biomed Online. 2011 Sep;23(3):372-9. doi: 10.1016/j.rbmo.2011.05.011. Epub 2011 May 26. Reprod Biomed Online. 2011. PMID: 21778114
-
Distribution of the Endocannabinoid System in the Central Nervous System.Handb Exp Pharmacol. 2015;231:59-93. doi: 10.1007/978-3-319-20825-1_3. Handb Exp Pharmacol. 2015. PMID: 26408158 Review.
-
Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.Histochem Cell Biol. 2019 Jan;151(1):5-20. doi: 10.1007/s00418-018-1719-0. Epub 2018 Sep 8. Histochem Cell Biol. 2019. PMID: 30196316 Free PMC article.
-
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Neuro Endocrinol Lett. 2004. PMID: 15159678 Review.
Cited by
-
Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.SAGE Open Med. 2021 Mar 9;9:20503121211000909. doi: 10.1177/20503121211000909. eCollection 2021. SAGE Open Med. 2021. PMID: 33786179 Free PMC article. Review.
-
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional-motivational reactivity.Psychopharmacology (Berl). 2012 Dec;224(4):573-9. doi: 10.1007/s00213-012-2785-y. Epub 2012 Jul 10. Psychopharmacology (Berl). 2012. PMID: 22776995 Free PMC article.
-
Resilience to meet the challenge of addiction: psychobiology and clinical considerations.Alcohol Res. 2012;34(4):506-15. Alcohol Res. 2012. PMID: 23584116 Free PMC article.
-
Roadmap for the expression of canonical and extended endocannabinoid system receptors and metabolic enzymes in peripheral organs of preclinical animal models.Physiol Rep. 2024 Feb;12(4):e15947. doi: 10.14814/phy2.15947. Physiol Rep. 2024. PMID: 38408761 Free PMC article.
-
Practical Considerations for the Use of Cannabis in Cancer Pain Management-What a Medical Oncologist Should Know.J Clin Med. 2022 Aug 27;11(17):5036. doi: 10.3390/jcm11175036. J Clin Med. 2022. PMID: 36078963 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous